Editorial
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Jul 26, 2025; 17(7): 109690
Published online Jul 26, 2025. doi: 10.4330/wjc.v17.i7.109690
Transcatheter aortic valve replacement or surgical aortic valve replacement: Establishing a middle ground
Sukhdeep Bhogal, Tarun Bhandari, Akash Batta, Bishav Mohan
Sukhdeep Bhogal, Department of Cardiology, Sovah Health, Martinsville, VA 24112, United States
Tarun Bhandari, Department of Cardiology, Medical University of South Carolina Health Heart and Vascular, Camden, SC 29020, United States
Akash Batta, Bishav Mohan, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana 141001, Punjab, India
Author contributions: Bhogal S and Batta A designed the editorial; Bhogal S and Bhandari T performed the literature review and data collection; Bhogal S and Mohan B supervised the manuscript and provided key feedback and suggestions; Bhogal S and Batta A analyzed the data and wrote the manuscript and subsequently revised it; All authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Akash Batta, Associate Professor, Department of Cardiology, Dayanand Medical College and Hospital, Tagore Nagar, Civil Lines, Ludhiana 141001, Punjab, India. akashbatta02@gmail.com
Received: May 18, 2025
Revised: June 15, 2025
Accepted: July 7, 2025
Published online: July 26, 2025
Processing time: 65 Days and 13.9 Hours
Core Tip

Core Tip: In the last few years, transcatheter aortic valve replacement (TAVR) has emerged as a formidable and preferred alternative to surgical aortic valve replacement (SAVR) for the treatment of symptomatic patients with severe aortic stenosis across all risk strata owing to the results of large randomized controlled trials (RCTs). Moradi et al in their metanalysis of RCTs provide a comprehensive insight into TAVR vs SAVR in terms of mortality, procedural complications, and post-procedure adverse events. In this editorial, we discuss the current status of TAVR vs SAVR and shed light on comparative analysis of both modalities to establish a middle ground.